| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer
1 company
Khoja Hamid serves as a Chief Scientific Officer at FBLG. Across recent SEC filings that breaks down to 3 buys and 0 sells. Those positions are worth an estimated $60K at current prices.
Historically, Khoja Hamid's trades have earned a below-average insider score of 45/100 across 3 rated trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of -15.3%.
The biggest single holding is FBLG (~$60K) as Chief Scientific Officer. Net of sales, the recent Form 4 record there shows accumulation of 60,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 4, 2026 | FBLG Fibrobiologics, Inc. | Chief Scientific Officer | Buy | 30,000 | $0.38 | $11,400.00 | +96.0% | +177.3% | - | |
| May 27, 2025 | FBLG Fibrobiologics, Inc. | Chief Scientific Officer | Buy | 20,000 | $0.84 | $16,800.00 | +177.8% | -24.7% | +37.9% | |
| Aug 12, 2024 | FBLG Fibrobiologics, Inc. | Chief Scientific Officer | Buy | 10,000 | $1.90 | $19,000.00 | +800.0% | +88.5% | -68.6% |